The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
|
---|---|
Published in |
Frontiers in oncology, July 2021
|
DOI | 10.3389/fonc.2021.672500 |
Pubmed ID | |
Authors |
Sebastian Bauer, Suzanne George, Margaret von Mehren, Michael C. Heinrich |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 12% |
Student > Postgraduate | 5 | 10% |
Student > Bachelor | 4 | 8% |
Other | 3 | 6% |
Student > Ph. D. Student | 3 | 6% |
Other | 5 | 10% |
Unknown | 23 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 22% |
Biochemistry, Genetics and Molecular Biology | 8 | 16% |
Agricultural and Biological Sciences | 2 | 4% |
Chemistry | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 1 | 2% |
Unknown | 24 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2021.
All research outputs
#20,167,676
of 25,655,374 outputs
Outputs from Frontiers in oncology
#9,451
of 22,758 outputs
Outputs of similar age
#320,280
of 449,029 outputs
Outputs of similar age from Frontiers in oncology
#510
of 1,368 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,029 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,368 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.